# Molecular Templates Inc. (MTEM)

Source: https://www.quantisnow.com/company/MTEM
Generated: 2026-11-14T00:20:54.548Z

- Ticker: MTEM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2005
- Website: mtem.com

## About

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other diseases. Its proprietary drug platform technology is engineered toxin bodies (ETBs). The company's lead drug candidate is MT-3724 that is in a Phase II clinical trial for the treatment of relapsed and refractory diffuse large B-cell lymphoma; and Phase II clinical trial for treating non-Hodgkin's lymphoma. It also develops MT-4019, engineered toxin body targeting CD38; TAK-169 targeting CD38 is in Phase I clinical trial; MT-5111 targeting HER2 is in Phase I clinical trial; and MT-6402 with antigen seeding targeting PD-L1. The company has an agreement with Takeda Pharmaceutical Company Limited to develop CD38-targeted engineered toxin bodies for the treatment of patients with diseases, such as multiple myeloma; and a strategic research collaboration with Vertex Pharmaceuticals Incorporated to discover and develop novel targeted biologic therapies for applications outside of oncology; and Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. is headquartered in Austin, Texas.

## Latest MTEM news and filings

- 2026-07-16 12:30 UTC [RapidPulse Secures Oversubscribed $48M Series B Financing to Advance Clinical Development of Next-Generation Stroke Aspiration Technology](https://www.quantisnow.com/insight/rapidpulse-secures-oversubscribed-48m-series-b-financing-to-advance-clinical-6639119)
- 2025-05-14 20:30 UTC [Leadership Update] [Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights](https://www.quantisnow.com/insight/calidi-biotherapeutics-reports-first-quarter-2025-financial-results-and-recent-6039338)
- 2025-04-23 12:00 UTC [Leadership Update] [Calidi Biotherapeutics Announces Chief Executive Officer Transition and Appointment of Eric Poma, Ph.D. as CEO and Director](https://www.quantisnow.com/insight/calidi-biotherapeutics-announces-chief-executive-officer-transition-and-appointment-of-5997352)
- 2025-01-02 21:13 UTC [SEC Form 8-K] [SEC Form 8-K filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-molecular-templates-inc-5829323)
- 2024-12-19 21:11 UTC [SEC Form 8-K] [SEC Form 8-K filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-molecular-templates-inc-5820498)
- 2024-12-19 21:10 UTC [Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules](https://www.quantisnow.com/insight/molecular-templates-announces-notice-of-delisting-and-failure-to-satisfy-5820479)
- 2024-12-04 21:10 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-molecular-templates-inc-5800255)
- 2024-12-04 21:05 UTC [SEC Form 8-K] [SEC Form 8-K filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-molecular-templates-inc-5800193)
- 2024-12-04 11:04 UTC [SEC Form 8-K] [SEC Form 8-K filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-molecular-templates-inc-5799311)
- 2024-12-02 22:06 UTC [Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements](https://www.quantisnow.com/insight/molecular-templates-announces-receipt-of-expected-notification-of-deficiency-from-5796400)
- 2024-11-26 21:35 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-molecular-templates-inc-5792216)
- 2024-11-26 21:31 UTC [SEC Form 8-K] [Molecular Templates Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/molecular-templates-inc-filed-sec-form-8-k-other-events-5792185)
- 2024-11-19 02:49 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-molecular-templates-inc-5781606)
- 2024-11-19 02:12 UTC [SEC Form 4] [Large owner Biotech Target N V sold $845,833 worth of shares (1,279,820 units at $0.66), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-biotech-target-n-v-sold-845833-worth-of-5781580)
- 2024-11-15 11:05 UTC [SEC Form NT 10-Q filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-molecular-templates-inc-5777951)
- 2024-11-14 21:37 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-molecular-templates-inc-5776586)
- 2024-11-12 14:31 UTC [SEC Schedule 13G] [Amendment: SEC Form SC 13G/A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13ga-filed-by-molecular-templates-inc-5765610)
- 2024-10-28 21:20 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-molecular-templates-inc-5740407)
- 2024-10-17 21:05 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-molecular-templates-inc-5729482)
- 2024-10-11 20:39 UTC [SEC Form 8-K] [SEC Form 8-K filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-molecular-templates-inc-5723629)
- 2024-10-04 20:02 UTC [SEC Form 8-K] [SEC Form 8-K filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-molecular-templates-inc-5716949)
- 2024-09-30 21:41 UTC [SEC Form 4] [SEC Form 4 filed by Director Lalande Kevin M.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-lalande-kevin-m-5708942)
- 2024-09-30 21:37 UTC [SEC Form 4] [SEC Form 4 filed by Director Gruia Gabriela](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-gruia-gabriela-5708940)
- 2024-09-30 21:36 UTC [SEC Form 4] [SEC Form 4 filed by Director Selick Harold E](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-selick-harold-e-5708937)
- 2024-09-30 21:36 UTC [SEC Form 4] [SEC Form 4 filed by Director Hoffmann Dave](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-hoffmann-dave-5708936)
- 2024-09-30 21:35 UTC [SEC Form 4] [SEC Form 4 filed by Director Sanders Corazon (Corsee) D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-sanders-corazon-corsee-d-5708934)
- 2024-09-27 20:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-molecular-templates-inc-5706946)
- 2024-08-14 20:36 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-molecular-templates-inc-5659649)
- 2024-08-14 20:26 UTC [SEC Form 8-K] [Molecular Templates Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/molecular-templates-inc-filed-sec-form-8-k-results-of-operations-5659468)
- 2024-08-14 20:21 UTC [Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update](https://www.quantisnow.com/insight/molecular-templates-inc-reports-second-quarter-2024-financial-results-and-5659410)
- 2024-08-13 20:44 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-molecular-templates-inc-5657339)
- 2024-08-13 20:43 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-molecular-templates-inc-5657328)
- 2024-06-03 12:19 UTC [Market Chatter] [Molecular Templates Provided An Update On Its Clinical-Stage Programs](https://www.quantisnow.com/insight/molecular-templates-provided-an-update-on-its-clinical-stage-programs-5531360)
- 2024-06-03 12:13 UTC [SEC Form 8-K] [Molecular Templates Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/molecular-templates-inc-filed-sec-form-8-k-other-events-financial-5531323)
- 2024-06-03 12:11 UTC [Molecular Templates, Inc. Provides Interim Update](https://www.quantisnow.com/insight/molecular-templates-inc-provides-interim-update-5531310)
- 2024-05-15 21:21 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-molecular-templates-inc-5494553)
- 2024-05-15 21:18 UTC [SEC Form 8-K] [Molecular Templates Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/molecular-templates-inc-filed-sec-form-8-k-results-of-operations-5494519)
- 2024-05-15 21:13 UTC [Market Chatter] [Molecular Templates Q1 2024 GAAP EPS $0.08 Beats $(0.78) Estimate, Sales $11.09M Beat $5.90M Estimate](https://www.quantisnow.com/insight/molecular-templates-q1-2024-gaap-eps-008-beats-078-estimate-5494464)
- 2024-05-15 21:11 UTC [Molecular Templates, Inc. Reports First Quarter  2024 Financial Results and Corporate Update](https://www.quantisnow.com/insight/molecular-templates-inc-reports-first-quarter-2024-financial-results-and-5494455)
- 2024-05-06 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Molecular Templates Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-molecular-templates-inc-5460419)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MTEM
- Earnings history: https://www.quantisnow.com/earnings/MTEM
- Dividend history: https://www.quantisnow.com/dividends/MTEM
- Insider transactions: https://www.quantisnow.com/insiders/MTEM
- Options chain: https://www.quantisnow.com/options/MTEM
- SEC 8-K filings only: https://www.quantisnow.com/company/MTEM/8-k
- RSS and alerts for MTEM: https://www.quantisnow.com/docs/rss-feeds.md